Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis
Prospective Analysis of Hemodialysis Reliable Outflow (HeRO) Vascular Access Graft vs. Cuffed Catheter Access in Hemodialysis
Status: Enrolling
Updated:  2/16/2016
St. Clair Specialty Physicians
mi
from
Detroit, MI
HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis
Prospective Analysis of Hemodialysis Reliable Outflow (HeRO) Vascular Access Graft vs. Cuffed Catheter Access in Hemodialysis
Status: Enrolling
Updated: 2/16/2016
St. Clair Specialty Physicians
mi
from
Detroit, MI
Click here to add this to my saved trials
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
New York, NY
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Rosedale, NY
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Rosedale, NY
Click here to add this to my saved trials
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
A Phase 2, Randomized, Double-blind, Placebo-controlled, Fixed-dose, Parallel-group, Multicenter, Efficacy, and Safety Study of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Miami, FL
Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  2/18/2016
Clinical Research Facility
mi
from
Orlando, FL
Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 2/18/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated:  2/18/2016
Site Reference ID/Investigator# 137332
mi
from
Grafton, Auckland,
Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Status: Enrolling
Updated: 2/18/2016
Site Reference ID/Investigator# 137332
mi
from
Grafton, Auckland,
Click here to add this to my saved trials
Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC
Alterations in Renal Blood Flow as a Consequence of Percutaneous Nephrolithotomy (PERC)
Status: Enrolling
Updated:  2/22/2016
IU Health Methodist Hospital
mi
from
Indianapolis, IN
Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC
Alterations in Renal Blood Flow as a Consequence of Percutaneous Nephrolithotomy (PERC)
Status: Enrolling
Updated: 2/22/2016
IU Health Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Red Blood Cell Lifespan
Red Blood Cell Lifespan and Inflammation in Dialysis Patients
Status: Enrolling
Updated:  2/22/2016
Yorkville Dialysis Center
mi
from
New York, NY
Red Blood Cell Lifespan
Red Blood Cell Lifespan and Inflammation in Dialysis Patients
Status: Enrolling
Updated: 2/22/2016
Yorkville Dialysis Center
mi
from
New York, NY
Click here to add this to my saved trials
Comparison of Body Hydration State in Hemodialysis Patients
Comparison of Body Hydration State in Hemodialysis Patients With the Hydra 4200 and ZOE (100 and 5 kHZ) Bioimpedance Devices
Status: Enrolling
Updated:  2/22/2016
Yorkville Dialysis
mi
from
New York, NY
Comparison of Body Hydration State in Hemodialysis Patients
Comparison of Body Hydration State in Hemodialysis Patients With the Hydra 4200 and ZOE (100 and 5 kHZ) Bioimpedance Devices
Status: Enrolling
Updated: 2/22/2016
Yorkville Dialysis
mi
from
New York, NY
Click here to add this to my saved trials
Hemodialysis Vascular Access Imaging Study
Contact-Free Video Imaging of Arteriovenous Fistulas In Chronic Hemodialysis Patients
Status: Enrolling
Updated:  2/22/2016
Renal Research Institute
mi
from
New York, NY
Hemodialysis Vascular Access Imaging Study
Contact-Free Video Imaging of Arteriovenous Fistulas In Chronic Hemodialysis Patients
Status: Enrolling
Updated: 2/22/2016
Renal Research Institute
mi
from
New York, NY
Click here to add this to my saved trials
Intradialytic Drug Removal by Short-daily Hemodialysis
Intradialytic Drug Removal by Short-daily Hemodialysis
Status: Enrolling
Updated:  2/24/2016
Indiana University School of Medicine
mi
from
Indianapolis, IN
Intradialytic Drug Removal by Short-daily Hemodialysis
Intradialytic Drug Removal by Short-daily Hemodialysis
Status: Enrolling
Updated: 2/24/2016
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Birmingham, AL
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Chattanooga, TN
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Los Angeles, CA
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Chicago, IL
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Lake Success, NY
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Columbus, OH
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Duncansville, PA
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Carrollton, TX
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Carrollton, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Investigational Site
mi
from
Brussels,
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Investigational Site
mi
from
Brussels,
Click here to add this to my saved trials
Direct Renin Inhibition and the Kidney
Direct Renin Inhibition and the Kidney
Status: Enrolling
Updated:  2/26/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Direct Renin Inhibition and the Kidney
Direct Renin Inhibition and the Kidney
Status: Enrolling
Updated: 2/26/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance
Status: Enrolling
Updated:  3/1/2016
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance
Status: Enrolling
Updated: 3/1/2016
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
Status: Enrolling
Updated:  3/1/2016
New York University Langone Medical Center
mi
from
New York, NY
A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure
Status: Enrolling
Updated: 3/1/2016
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated:  3/3/2016
Emory University
mi
from
Atlanta, GA
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated: 3/3/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated:  3/3/2016
University of Wisconsin
mi
from
Madison, WI
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated: 3/3/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated:  3/3/2016
NIH Clinical Center
mi
from
Bethesda, MD
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated: 3/3/2016
NIH Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated:  3/3/2016
Swedish Medical Center
mi
from
Seattle, WA
Study of Tolerant Kidney Transplant Recipients
Identification and Mechanistic Investigations of Tolerant Transplant Recipients
Status: Enrolling
Updated: 3/3/2016
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
Massachusetts General Hospital
mi
from
Boston, MA
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
NYU Medical Center
mi
from
New York, NY
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
Cleveland Clinic
mi
from
Cleveland, OH
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
Harborview Medical Center
mi
from
Seattle, WA
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
University of California at San Francisco
mi
from
San Francisco, CA
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
Shands Hospital
mi
from
Gainesville, FL
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
Shands Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
The Indiana Heart Hospital
mi
from
Indianapolis, IN
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
The Indiana Heart Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
University of Massachusetts
mi
from
Worcester, MA
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
The Mayo Clinic
mi
from
Rochester, MN
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated:  3/7/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
Evaluation of the Safety and Effectiveness of the Zenith(R) Fenestrated AAA Endovascular Graft
Status: Enrolling
Updated: 3/7/2016
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
High Water Intake to Slow Progression of Polycystic Kidney Disease
The Effect of Water Loading on Urinary Biomarkers
Status: Enrolling
Updated:  3/7/2016
New York University Langone Medical Center
mi
from
New York, NY
High Water Intake to Slow Progression of Polycystic Kidney Disease
The Effect of Water Loading on Urinary Biomarkers
Status: Enrolling
Updated: 3/7/2016
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Reference Group Trial for The ONE Study
Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
Status: Enrolling
Updated:  3/8/2016
Massachusetts General Hospital
mi
from
Boston, MA
Reference Group Trial for The ONE Study
Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
Status: Enrolling
Updated: 3/8/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Reference Group Trial for The ONE Study
Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
Status: Enrolling
Updated:  3/8/2016
University of California at San Francisco
mi
from
San Francisco, CA
Reference Group Trial for The ONE Study
Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
Status: Enrolling
Updated: 3/8/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Reference Group Trial for The ONE Study
Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
Status: Enrolling
Updated:  3/8/2016
CHU de Nantes Hotel-Dieu
mi
from
Nantes,
Reference Group Trial for The ONE Study
Reference Group Trial for The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
Status: Enrolling
Updated: 3/8/2016
CHU de Nantes Hotel-Dieu
mi
from
Nantes,
Click here to add this to my saved trials
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Status: Enrolling
Updated:  3/8/2016
University of Colorado Clinical and Translational Research Center (CTRC) Outpatient Clinic
mi
from
Aurora, CO
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Status: Enrolling
Updated: 3/8/2016
University of Colorado Clinical and Translational Research Center (CTRC) Outpatient Clinic
mi
from
Aurora, CO
Click here to add this to my saved trials
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Status: Enrolling
Updated:  3/8/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Interleukin-1 Trap to Treat Vascular Dysfunction in Chronic Kidney Disease (CKD)
Status: Enrolling
Updated: 3/8/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated:  3/8/2016
CSG Investigational Site (#157)
mi
from
Birmingham, AL
Pyridorin in Diabetic Nephropathy
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin (Pyridoxamine Dihydrochloride) in Subjects With Nephropathy Due to Type 2 Diabetes (PIONEER)
Status: Enrolling
Updated: 3/8/2016
CSG Investigational Site (#157)
mi
from
Birmingham, AL
Click here to add this to my saved trials